Related Experiment Videos
Squaric acid immunotherapy for warts in children.
N B Silverberg1, J K Lim, A S Paller
1Department of Pediatrics and Dermatology, Northwestern University Medical School, Children's Memorial Hospital, Chicago, IL 60614, USA.
Journal of the American Academy of Dermatology
|April 25, 2000
Summary
Squaric acid dibutylester (SADBE) topical immunotherapy offers a safe and effective home treatment for childhood warts. This study found SADBE significantly cleared warts in over half of pediatric patients with minimal side effects.
Area of Science:
- Pediatric Dermatology
- Immunotherapy
- Dermatological Treatments
Background:
- Warts are common pediatric skin infections caused by human papillomavirus (HPV).
- Anti-HPV immunity is crucial for wart clearance, and contact sensitizers may enhance this response.
- Squaric acid dibutylester (SADBE) is a non-carcinogenic sensitizing agent with established use in treating alopecia areata.
Purpose of the Study:
- To investigate the efficacy and safety of home-applied Squaric acid dibutylester (SADBE) as a therapeutic option for pediatric warts.
- To test the hypothesis that SADBE home application can be an effective treatment for common warts in children.
Main Methods:
- An open-label, retrospective study involved 61 children diagnosed with warts.
- Patients underwent initial sensitization with 2% SADBE on the forearm.
- Therapy involved home application of 0.2% SADBE to warts, 3-7 nights weekly for a minimum of 3 months.
Main Results:
- Complete wart clearance was achieved in 58% (34/61) of patients, with an average treatment duration of 7 weeks.
- Partial clearance was observed in 18% (11/61), while 24% (14/61) showed no response.
- Clearance was associated with plantar wart distribution, duration under 2 years, and use as a first-line treatment. Mild side effects, primarily localized erythema, occurred in one-third of patients, with only 2 discontinuing therapy.
Conclusions:
- Topical immunotherapy using Squaric acid dibutylester (SADBE) presents a safe and effective treatment choice for managing warts in pediatric patients at home.
- SADBE demonstrates significant potential as a readily accessible and well-tolerated therapeutic modality for childhood warts.